Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Hepatitis Treatment Market

Hepatitis Treatment Market Trends

  • Report ID: GMI10910
  • Published Date: Aug 2024
  • Report Format: PDF

Hepatitis Treatment Market Trends

The expansion of the market is significantly bolstered by the increasing prevalence of hepatitis infections. Enhanced surveillance and reporting systems have led to a more accurate understanding of the burden of hepatitis, prompting public health interventions and targeted awareness campaigns. These efforts have effectively raised public awareness about the importance of hepatitis prevention, screening, and treatment. This heightened awareness has led to more individuals seeking medical advice and intervention, thereby driving the demand for advanced hepatitis diagnostics and therapeutics. Therefore, the rise in the prevalence of hepatitis infections and the corresponding increase in public and healthcare professional awareness have significantly accelerated the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The hepatitis treatment industry size was USD 22.2 billion in 2023 and is projected to grow at a 3.5% CAGR due to the rising incidence of hepatitis B and C viruses and the greater global awareness of these conditions.

The hepatitis treatment industry from the hepatitis C segment recorded USD 9.8 billion in 2023, driven by rising infection rates and advancements in anti-viral treatments.

North America hepatitis treatment market will expand at a 3.7% CAGR through 2032, supported by the prevalence of hepatitis B and C, advancements in antiviral therapies, a strong healthcare infrastructure, and enhanced awareness and screening programs.

Barnes-Jewish Hospital, Bumrungrad International Hospital, Cedars-Sinai, Cleveland Clinic, Mayo Clinic, AbbVie Inc., Biocon, Inc., Bristol-Myers Squibb Company, Dynavax Technologies, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmith Kline plc, Lupin Limited, Merck & Co., Inc., and Novartis AG.

Hepatitis Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 400
  • Countries covered: 23
  • Pages: 231
 Download Free Sample